Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02285907 · ClinicalTrials.gov registry record · NA
Protein Quality on Appetite Control, Reward-driven Eating, & Subsequent Food Intake
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02285907: Completed NA study, sponsored by University of Missouri-Columbia.
NCT02285907 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02285907, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To determine whether the consumption of a beef-rich lunch improves appetite control, satiety, and energy intake regulation while reducing food reward and food cravings compared to the consumption of a soy-rich lunch when matched for macronutrients and fiber content or when match for serving size. The mechanisms of action surrounding the differential responses of beef versus soy proteins were also explored.
Primary Outcome
Eating initiation will be measured as the time lapse between consuming the intervention and requesting dinner.
Interventions
- OTHER Macronutrient and Fiber Matched BEEF
- OTHER Macronutrient and Fiber Matched SOY
- OTHER Serving Size Matched BEEF
- OTHER Serving Size Matched SOY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT02285907 record still lists
NCT02285907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Macronutrient and Fiber Matched BEEF is the first listed.
NCT02285907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02285907 about?
NCT02285907 is a clinical study titled "Protein Quality on Appetite Control, Reward-driven Eating, & Subsequent Food Intake". To determine whether the consumption of a beef-rich lunch improves appetite control, satiety, and energy intake regulation while reducing food reward and food cravings compared to the consumption of a soy-rich lunch when matched for macronutrients and fiber content or when match for serving size. Th...
What is the current status of trial NCT02285907?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2012-05. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02285907?
The interventions under investigation include: Macronutrient and Fiber Matched BEEF (OTHER), Macronutrient and Fiber Matched SOY (OTHER), Serving Size Matched BEEF (OTHER), Serving Size Matched SOY (OTHER).
Who is sponsoring clinical trial NCT02285907?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02285907's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia